サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439398

画像誘導手術機器 - 世界市場の考察、競合情勢、市場予測（2030年）

Image Guided Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
画像誘導手術機器 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の画像誘導手術機器の市場規模は、2023年に55億4,087万米ドル、2030年までに77億6,522万米ドルに達し、2024年～2030年の予測期間にCAGRで5.81％の成長が見込まれます。画像誘導手術機器市場は、慢性疾患に罹患しやすい老年人口の負担の増大や、心血管、がん、神経疾患などの慢性疾患の有病率の世界的な上昇などの要因により、大幅な市場成長を示しています。さらに、画像誘導手術機器の承認の段階的な増加や、製品の急速な技術の進歩、低侵襲手術の需要の増加などが、市場における画像誘導手術機器へのニーズを生み出しています。そのため、画像誘導手術機器市場は、2024年～2030年の予測期間に大幅なCAGRで成長する見込みです。

画像誘導手術機器の市場力学

画像誘導手術機器市場の成長に影響を与える主な要因の1つは、世界中でのさまざまな慢性疾患の有病率の増加です。

例えば、米国疾病予防管理センター（CDC）の最新の調査によると、慢性疾患である心臓病、がん、糖尿病は米国における死亡と身体障害の主因となっています。そして、米国では成人の10人に6人が慢性疾患を患っています。また、European Chronic Disease Allianceによれば、慢性疾患は欧州における最大の死因であり、疾病負担全体の77％、死亡者全体の86％を占めています。

さらに、GLOBOCANが2020年に発表したデータでは、世界中で合計1,929万2,789件の新規がん症例が報告されています。同データによると、2020年における全世界のあらゆる種類のがんの5年間の有病者数は5,055万287人です。Global Cancer Observatoryによると、2020年、アジアにおけるがん罹患率は人口10万人当たり169.1人に上昇し、世界のがん罹患率の49.3％を占めました。もっとも多いがんは肺がん（13.8％）、乳がん（10.8％）、大腸がん（10.6％）です。

加えて、慢性疾患にかかりやすい老年人口の負担の増大は、外科手術の件数を増やし、ひいては画像誘導手術機器の需要を増加させます。例えば、WHO（2023）が提供したデータによると、2020年には世界中で約10億人が60歳以上になっています。2050年までに、60歳以上の老年人口は倍増し、約21億人になると予測されています。また、80歳以上の人口は2020年～2050年に3倍に増え、4億2,600万人に達すると推定されています。

製品の発売や認可の増加も、画像誘導手術機器市場を急成長させる見込みです。2022年9月、Strykerは脊椎用Q Guidance Systemの発売を発表しました。このシステムは、再設計されたカメラが提供する新しい光学追跡オプションと、新しく発売されたSpine Guidance Softwareの洗練されたアルゴリズムを組み合わせたものです。Q Guidance Systemとともに使用されるSpine Guidance Softwareは、開腹手術または経皮的コンピューター支援手術を可能にするためのプランニングと術中ガイダンスシステムとして意図されており、13歳以上の小児患者への使用についてFDAの認可を受けた最初の脊椎ナビゲーションソフトウェアです。

また、2022年7月、Fujifilm Healthcare Americas Corporationは、デジタルX線撮影と透視機能を1つのプラットフォームに統合したポータブル機器「FDR Cross」を発売しました。この機器は、画像誘導手術に用いる追加の機器の必要性を低減します。

このため、上記の要因が総合的に、2024年～2030年の予測期間に画像誘導手術機器市場全体を促進します。

しかし、画像誘導手術機器の高いコストや、厳格な規制当局の承認などが、画像誘導手術機器市場の成長にとっての課題となる可能性があります。

当レポートでは、世界の画像誘導手術機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 画像誘導手術機器市場レポートのイントロダクション

第2章 画像誘導手術機器市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 画像誘導手術機器市場の主な要因の分析

  • 画像誘導手術機器市場の促進要因
    • 慢性疾患の有病率の増加
    • 高齢者の負担の増大
    • 画像誘導手術機器の承認の段階的な増加
    • 製品の急速な技術の進歩
  • 画像誘導手術機器市場の抑制要因と課題
    • 画像誘導手術機器の高いコスト
    • 厳格な規制当局の承認
  • 画像誘導手術機器市場の機会
    • 新興国における画像誘導手術機器の需要の拡大
    • 主要企業のプレゼンスにより、市場はより機会主義的になる

第5章 画像誘導手術機器市場のポーターのファイブフォース分析

第6章 画像誘導手術機器市場に対するCOVID-19の影響分析

第7章 画像誘導手術機器の市場レイアウト

  • 製品タイプ別
    • 内視鏡
    • 超音波システム
    • MRIシステム
    • CTシステム
    • X線透視システム
    • その他
  • 用途別
    • 神経手術
    • 整形外科手術
    • 耳鼻咽喉科（ENT）手術
    • 腫瘍手術
    • その他の用途
  • エンドユーザー別
    • 病院
    • 専門クリニック
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 画像誘導手術機器市場の企業と製品のプロファイル

  • Medtronic
  • Koninklijke Philips N.V.
  • Siemens Healthcare GmbH
  • General Electric
  • Perlong Medical Equipment Co., Ltd.
  • Brainlab AG
  • Olympus Corporation
  • Stryker
  • Abbott
  • Getinge AB
  • joimax® GmbH
  • KARL STORZ SE & Co. KG
  • Sea Spine
  • OnLume Inc.
  • IMRIS
  • Shimadzu Corporation
  • FUJIFILM Holdings
  • Nanjing Perlove Medical Equipment Co., Ltd.
  • Allengers
  • ClaroNav

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項と連絡先

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Image Guided Surgery Devices Market
  • Table 3: Image Guided Surgery Devices Market Analysis in Global (2021-2030)
  • Table 4: Image Guided Surgery Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5: Image Guided Surgery Devices Market Analysis in Global by Application (2021-2030)
  • Table 6: Image Guided Surgery Devices Market Analysis in Global by End-User (2021-2030)
  • Table 7: Image Guided Surgery Devices Market Analysis in Global by Geography (2021-2030)
  • Table 8: Image Guided Surgery Devices Market Analysis in North America (2021-2030)
  • Table 9: Image Guided Surgery Devices Market Analysis in North America by Country (2021-2030)
  • Table 10: Image Guided Surgery Devices Market Analysis in the US (2021-2030)
  • Table 11: Image Guided Surgery Devices Market Analysis in Canada (2021-2030)
  • Table 12: Image Guided Surgery Devices Market Analysis in Mexico (2021-2030)
  • Table 13: Image Guided Surgery Devices Market Analysis in Europe (2021-2030)
  • Table 14: Image Guided Surgery Devices Market Analysis in Europe by Country (2021-2030)
  • Table 15: Image Guided Surgery Devices Market Analysis in France (2021-2030)
  • Table 16: Image Guided Surgery Devices Market Analysis in Germany (2021-2030)
  • Table 17: Image Guided Surgery Devices Market Analysis in the UK (2021-2030)
  • Table 18: Image Guided Surgery Devices Market Analysis in Italy (2021-2030)
  • Table 19: Image Guided Surgery Devices Market Analysis in Spain (2021-2030)
  • Table 20: Image Guided Surgery Devices Market Analysis in the Rest of Europe (2021-2030)
  • Table 21: Image Guided Surgery Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 22: Image Guided Surgery Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 23: Image Guided Surgery Devices Market Analysis in China (2021-2030)
  • Table 24: Image Guided Surgery Devices Market Analysis in Japan (2021-2030)
  • Table 25: Image Guided Surgery Devices Market Analysis in India (2021-2030)
  • Table 26: Image Guided Surgery Devices Market Analysis in Australia (2021-2030)
  • Table 27: Image Guided Surgery Devices Market Analysis in South Korea (2021-2030)
  • Table 28: Image Guided Surgery Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 29: Image Guided Surgery Devices Market Analysis in the Rest of the World (2021-2030)
  • Table 30: Image Guided Surgery Devices Market Analysis in the Rest of the World by Region (2021-2030)
  • Table 31: Image Guided Surgery Devices Market Analysis in the Middle East (2021-2030)
  • Table 32: Image Guided Surgery Devices Market Analysis in Africa (2021-2030)
  • Table 33: Image Guided Surgery Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Image Guided Surgery Devices Market
  • Figure 3: Image Guided Surgery Devices Market Analysis in Global (2021-2030)
  • Figure 4: Image Guided Surgery Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5: Image Guided Surgery Devices Market Analysis in Global by Application (2021-2030)
  • Figure 6: Image Guided Surgery Devices Market Analysis in Global by End-User (2021-2030)
  • Figure 7: Image Guided Surgery Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 8: Image Guided Surgery Devices Market Analysis in North America (2021-2030)
  • Figure 9: Image Guided Surgery Devices Market Analysis in North America by Country (2021-2030)
  • Figure 10: Image Guided Surgery Devices Market Analysis in the US (2021-2030)
  • Figure 11: Image Guided Surgery Devices Market Analysis in Canada (2021-2030)
  • Figure 12: Image Guided Surgery Devices Market Analysis in Mexico (2021-2030)
  • Figure 13: Image Guided Surgery Devices Market Analysis in Europe (2021-2030)
  • Figure 14: Image Guided Surgery Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 15: Image Guided Surgery Devices Market Analysis in France (2021-2030)
  • Figure 16: Image Guided Surgery Devices Market Analysis in Germany (2021-2030)
  • Figure 17: Image Guided Surgery Devices Market Analysis in the UK (2021-2030)
  • Figure 18: Image Guided Surgery Devices Market Analysis in Italy (2021-2030)
  • Figure 19: Image Guided Surgery Devices Market Analysis in Spain (2021-2030)
  • Figure 20: Image Guided Surgery Devices Market Analysis in the Rest of Europe (2021-2030)
  • Figure 21: Image Guided Surgery Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 22: Image Guided Surgery Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 23: Image Guided Surgery Devices Market Analysis in China (2021-2030)
  • Figure 24: Image Guided Surgery Devices Market Analysis in Japan (2021-2030)
  • Figure 25: Image Guided Surgery Devices Market Analysis in India (2021-2030)
  • Figure 26: Image Guided Surgery Devices Market Analysis in Australia (2021-2030)
  • Figure 27: Image Guided Surgery Devices Market Analysis in South Korea (2021-2030)
  • Figure 28: Image Guided Surgery Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Image Guided Surgery Devices Market Analysis in the Rest of the World (2021-2030)
  • Figure 30: Image Guided Surgery Devices Market Analysis in the Rest of the World by Region (2021-2030)
  • Figure 31: Image Guided Surgery Devices Market Analysis in the Middle East (2021-2030)
  • Figure 32: Image Guided Surgery Devices Market Analysis in Africa (2021-2030)
  • Figure 33: Image Guided Surgery Devices Market Analysis in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Market Opportunities
  • Figure 37: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0196

Image-Guided Surgery Devices Market By Product Type (Endoscopes, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Systems, X-Ray Fluoroscopy Systems, And Others), By Application (Neurology, Orthopedic Surgery, Ear Nose Throat (ENT) Surgery, Oncology Surgery, And Other Application), By End-User (Hospitals, Specialty Clinics, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing growing prevalence of chronic disorder and the increasing burden of old age population prone to chronic diseases across the globe

The global image-guided surgery devices market was valued at USD 5,540.87 million in 2023, growing at a CAGR of 5.81% during the forecast period from 2024 to 2030 to reach USD 7,765.22 million by 2030. The image-guided surgery devices market is observing remarkable market growth due to the factors such as the escalating burden of the geriatric population prone to chronic diseases and the rising prevalence of chronic diseases such as cardiovascular, cancers, neurological, and others across the globe. Further, a gradual increase in approval of image-guided surgery devices, rapid technological advancement in the products, increasing demand for minimally invasive surgeries, and others will create a necessity for Image Guided Surgery Devices in the market. Therefore, the market for image-guided surgery devices is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Image-Guided Surgery Devices Market Dynamics:

One of the key factors influencing the growth of image-guided surgery devices in the market is the growing prevalence of various chronic disorders across the world.

For instance, according to the latest study provided by the Centers for Disease Control and Prevention (CDC), chronic diseases namely heart disease, cancer, and diabetes are the leading causes of death and disability in the US. The source stated that six in ten adults have a chronic disease, in the US. Also, according to European Chronic Disease Alliance, chronic diseases are the leading cause of mortality in Europe, representing 77% of the total disease burden and 86% of all deaths.

Further, the data published by GLOBOCAN in the year 2020 states that a total of 19,292,789 new cases of cancer were reported worldwide. As per the same data, the five-year prevalence for all types of cancer across the globe is 50,550,287, in 2020. As per Global Cancer Observatory, in 2020, the cancer incidence in Asia rose to 169.1 per 100,000 inhabitants, accounting for 49.3% of the global cancer incidence. The most common cancers were lung (13.8%), breast (10.8%), and colorectal (10.6%) cancers.

In addition, the increasing burden of the geriatric population prone to chronic disease will increase the number of surgical procedures, ultimately increasing the demand for image-guided surgery devices. For instance, according to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The source mentioned above also stated that by 2050, the elderly population aged 60 and above is expected to double in number representing about 2.1 billion people. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.

Increasing product launches and approvals will also upsurge the market of image-guided surgery devices. In September 2022, Stryker announced the launch of its Q Guidance System for spine applications. The System combines new optical tracking options provided by a redesigned camera and sophisticated algorithms of the newly launched Spine Guidance Software. When used with the Q Guidance System, the Spine Guidance Software is intended as a planning and intraoperative guidance system to enable open or percutaneous computer-assisted surgery and is the first spine navigation software to receive FDA clearance for use with pediatric patients aged 13 and older.

Also, in July 2022, Fujifilm Healthcare Americas Corporation launched the FDR Cross, a portable device that combines digital radiography and fluoroscopic capabilities in one platform. The device reduces the need for additional equipment for image-guided procedures.

Therefore, the factors stated above collectively will drive the overall image-guided surgery devices market during the forecast period from 2024-2030.

However, the high cost of the image-guided surgery devices, stringent regulatory approvals, and others may prove to be challenging factors for image-guided surgery devices market growth.

The image-guided surgery devices market was negatively impacted during the period of COVID- 19 pandemic during the initial few months owing to the lockdown impositions, and border closures, which led to the disruption in the manufacturing, supply, import, export, and other related activities of the IGS devices market. Furthermore, all non-elective surgery around the globe was suspended and most hospitals and clinics were overburdened in managing and treating patients affected by COVID-19. This causes a halt in major orthopedic, ENT, and oncology services, thereby negatively affecting device growth. However, with mass vaccination, the market is set to be normalized due to improved sales and resumed product developmental activities. Additionally, with the launch of new products in the market the industry for image-guided surgery devices is said to take off in the years followed by the pandemic. Thus, the above factors are anticipated to propel the market for image-guided surgery devices during the forecast period.

Image-Guided Surgery Devices Market Segment Analysis:

Image Guided Surgery Devices Market by Product Type (Endoscopes, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Systems, X-Ray Fluoroscopy Systems, and Others), Application (Neurology, Orthopedic Surgery, Ear Nose Throat (ENT) Surgery, Oncology Surgery, and Other Application), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the image-guided surgery devices market, Magnetic Resonance Imaging (MRI) Systems are expected to have a revenue share of 27.77% in the year 2023. This was primarily due to the usage of these devices in multiple surgeries and various advantages offered by them such as no use of radiation and being minimally invasive, among others offered by the category.

Moreover, it produces extremely clear, detailed images of soft-tissue structures as compared to X-ray and CT scans and helps surgeons to conduct accurate and effective surgical treatment. Unlike other systems such as X-ray and CT Scans that are based upon the use of radiation to create images of body structures, MRI does not involve the use of radiation, instead, it uses strong magnetic fields and radio waves to produce internal images of the body. The patients thereby are not exposed to harmful doses of radiation and remain safe from its effects.

Further, in image-guided surgery, it is possible to create hundreds of images from almost any direction and in any orientation with the help of MRI systems.

The growing technological advancements in MRI systems for image-guided surgery are another factor that is likely to increase their demand. For example, iMRI System is a ceiling-mounted MRI system developed by IMRIS, Deerfield Imaging, Inc. for imaging during surgical procedures in a hybrid operating room or a multi-room hybrid operating suite. It is the only iMRI System in the world with a magnet that travels on a ceiling-mounted rail system between the diagnostic room and adjacent operating rooms, bringing the magnet directly to the patient.

Therefore, owing to the aforementioned factors, the category Magnetic Resonance Imaging (MRI) Systems is expected to witness considerable growth eventually contributing to the overall growth of the global image-guided surgery devices market during the forecast period.

North America is expected to dominate the overall Image-Guided Surgery Devices Market:

Among all the regions, North America is expected to hold the largest share of 45.64% in the image-guided surgery devices market in 2022. This can be ascribed to the increasing prevalence of various chronic diseases such as neurology, cardiovascular, cancers, and orthopedic, among others. Furthermore, the surging burden of the geriatric population prone to chronic diseases, the rising research and development activities in the region associated with the launch of new image-guided surgery devices, and the strategic business activities by the key players to expand their product portfolio, and other are also driving the market growth in North America.

The growing prevalence of cardiology and cardiovascular disorders such as coronary artery disease, heart blockage, and heart attack, among others are expected to upsurge the demand for image-guided surgery in the region. According to the Centers for Disease Control and Prevention 2022 data, approximately 6.7% (18.1 million) of the population aged 20 and older had coronary artery disease, in 2022, in the US.

Further, according to the Canadian Institute for Health Information 2022 report, in 2020-2022, nearly 55,300 hip and 55,285 knee replacements were performed in Canada, which was 12.9% and 26.4% lower, respectively, compared with the number performed in 2019-2020.

Moreover, the increasing product launches, approvals, and other regulatory activities among the key players in the region will aid in increasing the demand for image guides surgery devices. For instance, in February 2020, OnLume received 510(k) clearance from the US Food & Drug Administration to market its first product, a fluorescence-guided surgery (FGS) system. The system is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries.

Also, in December 2022, ClaroNav, received Health Canada approval for its Navient ENT and Navient Cranial. Navient is an innovative image-guided navigation system, that utilizes the latest technologies in the field and brings simplicity, accuracy, and affordability to the surgical navigation system.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the image-guided surgery devices market.

Image-Guided Surgery Devices Market Key Players:

Some of the key market players operating in the image-guided surgery devices market include Medtronic, Koninklijke Philips N.V., Siemens Healthcare GmbH, General Electric, Perlong Medical Equipment Co., Ltd., Brainlab AG, Olympus Corporation, Stryker, Abbott, Getinge AB, joimax® GmbH, KARL STORZ SE & Co. KG, Sea Spine, OnLume Inc., IMRIS, Shimadzu Corporation, FUJIFILM Holdings, Nanjing Perlove Medical Equipment Co., Ltd., Allengers, ClaroNav, and others.

Recent Developmental Activities in the Image-Guided Surgery Devices Market:

In May 2022, Brainlab, a digital medical technology company, announced the majority acquisition of medPhoton GmbH, a Salzburg, Austria-based company, that develops and manufactures robotic imaging solutions for image-guided radiation therapy and surgery.

In April 2022, Medtronic announced a partnership with Surgical Theater to interface Surgical Theater's SyncAR(TM) augmented reality (AR) technology with Medtronic's StealthStation(TM) S8 surgical navigation system. This collaboration will enable neurosurgeons to use AR technology in real-time to enhance visualization during complex cranial procedures.

In December 2022, GE announced that it has completed the acquisition of BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners, LLC.

Key Takeaways from the Image Guided Surgery Devices Market Report Study

Market size analysis for current image-guided surgery devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the image-guided surgery devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global image-guided surgery devices market.

Various opportunities are available for the other competitor in the image-guided surgery devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current image-guided surgery devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for image-guided surgery devices market growth in the coming future?

Target Audience who can be benefited from this Image-Guided Surgery Devices Market Report Study

Image-guided surgery devices products providers

Research organizations and consulting companies

Image-guided surgery devices -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in image-guided surgery devices

Various end users who want to know more about the image-guided surgery devices market and the latest technological developments in the image-guided surgery devices market.

Frequently Asked Questions for the Image-Guided Surgery Devices Market:

1. What are image-guided surgery devices?

The image-guided surgery systems are employed in intraoperative procedures to accurately target tissue or tumor. It provides enhanced visualization through real-time monitoring thereby increasing the efficiency of surgeon's manifolds.

2. What is the global market for image-guided surgery Devices?

The global image-guided surgery devices market was valued at USD 5,540.87 million in 2023, growing at a CAGR of 5.81% during the forecast period from 2024 to 2030 to reach USD 7,765.22 million by 2030.

3. What are the drivers for the global image-guided surgery devices market?

The image-guided surgery devices market is witnessing positive market growth owing to the factors such as the growing prevalence of chronic disorders, the increasing burden of the old age population, the gradual increase in approval of image-guided surgery devices, rapid technological advancement in the products, surging demand of minimally invasive devices, increasing product launches and approvals, presence of key players in the market, and others will create an exigency for the image-guided surgery devices market.

4. Who are the key players operating in the global image-guided surgery devices market?

Some of the key market players operating in the image-guided surgery devices market include Medtronic, Koninklijke Philips N.V., Siemens Healthcare GmbH, General Electric, Perlong Medical Equipment Co., Ltd., Brainlab AG, Olympus Corporation, Stryker, Abbott, Getinge AB, joimax® GmbH, KARL STORZ SE & Co. KG, Sea Spine, OnLume Inc., IMRIS, Shimadzu Corporation, FUJIFILM Holdings, Nanjing Perlove Medical Equipment Co., Ltd., Allengers, ClaroNav, and others.

5. Which region has the highest share in the image-guided surgery devices market?

Among all the regions, North America is estimated to amass a significant revenue share in the global image-guided surgery devices market. This domination is due to the surging prevalence of various chronic diseases, escalating burden of the geriatric population, and the growing product development activities in the image-guided surgery devices sector in North America is expected to propel the overall market growth.

Table of Contents

1. Image Guided Surgery Devices Market Report Introduction

2. Image Guided Surgery Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Image Guided Surgery Devices Market Key Factors Analysis

  • 4.1. Image Guided Surgery Devices Market Drivers
    • 4.1.1. Growing prevalence of chronic disorders
    • 4.1.2. The increasing burden of the old age population
    • 4.1.3. Gradual increase in approval of image-guided surgery devices
    • 4.1.4. Rapid technological advancement in the products
  • 4.2. Image Guided Surgery Devices Market Restraints and Challenges
    • 4.2.1. High cost of the image-guided surgery devices
    • 4.2.2. Stringent regulatory approvals
  • 4.3. Image Guided Surgery Devices Market Opportunities
    • 4.3.1. Growing demand for image-guided surgery devices in emerging countries
    • 4.3.2. Due to the presence of key players market is more opportunistic

5. Image Guided Surgery Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Image-Guided Surgery Devices Market

7. Image Guided Surgery Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Endoscopes
    • 7.1.2. Ultrasound systems
    • 7.1.3. Magnetic resonance imaging (MRI) systems
    • 7.1.4. Computed tomography (CT) systems
    • 7.1.5. X-ray fluoroscopy systems
    • 7.1.6. Others
  • 7.2. By Application
    • 7.2.1. Neurology
    • 7.2.2. Orthopedic surgery
    • 7.2.3. Ear Nose Throat (ENT) surgery
    • 7.2.4. Oncology surgery
    • 7.2.5. Other application
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Specialty Clinics
    • 7.2.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.1.2. Canada Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.1.3. Mexico Image Guided Surgery Devices Market in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.2.2. Germany Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.2.4. Italy Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.2.5. Spain Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.2.6. Russia Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.2.7. Rest of Europe Image Guided Surgery Devices Market in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.3.2. Japan Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.3.3. India Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.3.4. Australia Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.3.5. South Korea Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia Pacific Image Guided Surgery Devices Market in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.4.2. Africa Image Guided Surgery Devices Market in USD million (2021-2030)
      • 7.4.4.3. South America Image Guided Surgery Devices Market in USD million (2021-2030)

8. Image Guided Surgery Devices Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Koninklijke Philips N.V.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Siemens Healthcare GmbH
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. General Electric
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Perlong Medical Equipment Co., Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Brainlab AG
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Olympus Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Stryker
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Abbott
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Getinge AB
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. joimax® GmbH
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. KARL STORZ SE & Co. KG
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Sea Spine
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. OnLume Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. IMRIS
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Shimadzu Corporation
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. FUJIFILM Holdings
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Nanjing Perlove Medical Equipment Co., Ltd.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Allengers
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. ClaroNav
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us